Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus

Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus

ABSTRACT Despite recent advances in therapy for chronic hepatitis C (CHC), the disease caused by genotype 3 virus (GEN3) is still considered a treatment challenge in certain patient subgroups. The aim of this retrospective study was to evaluate the effectiveness and safety of the peginterferon (Peg-...

Full description

Bibliographic Details
Main Authors: Aline Vitali Grando, Paulo Roberto Abrão Ferreira, Mário Guimarães Pessôa, Daniel Ferraz de Campos Mazo, Carlos Eduardo Brandão-Mello, Tânia Reuter, Ana de Lourdes Candolo Martinelli, Mário Peribanez Gonzalez, Ana Catharina Seixas-Santos Nastri, Aléia Faustina Campos, Max Igor Banks Ferreira Lopes, José David Urbaez Brito, Maria Cássia Mendes-Corrêa
Format: Article
Language:English
Published: Universidade de São Paulo 2017-11-01
Series:Revista do Instituto de Medicina Tropical de São Paulo
Subjects:
Hepatitis C
Chronic hepatitis C
Coinfection HCV-HIV
Interferons
Ribavirin
HCV genotypes
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652017005000239&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652017005000239&lng=en&tlng=en

Similar Items